Quoin Pharmaceuticals, Ltd.
QNRX
$6.97
-$0.18-2.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.37M | -5.00M | -4.35M | -3.95M | -3.70M |
| Total Depreciation and Amortization | 25.00K | 25.00K | 25.00K | 25.00K | 25.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 479.50K | 334.00K | 206.20K | 184.40K | 247.60K |
| Change in Net Operating Assets | 1.72M | -230.20K | -917.80K | 1.51M | -262.90K |
| Cash from Operations | -3.14M | -4.87M | -5.04M | -2.23M | -3.69M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.02M | 4.12M | -11.27M | 2.54M | 1.68M |
| Cash from Investing | 4.02M | 4.12M | -11.27M | 2.54M | 1.68M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -150.00K | -150.00K | -150.00K | -150.00K | -150.00K |
| Issuance of Common Stock | -- | 206.00K | 18.44M | 0.00 | 0.00 |
| Repurchase of Common Stock | -1.90K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -151.90K | 56.00K | 18.29M | -150.00K | -150.00K |
| Foreign Exchange rate Adjustments | -400.00 | 500.00 | -600.00 | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 721.10K | -693.60K | 1.99M | 162.40K | -2.15M |